Feu vert de l’EMA à l’administration du vaccin Pfizer-BioNTech aux 12 à 15 ans


Illustration image
Photo News

The European Medicines Agency (EMA) has approved the use of the anti-Covid Pfizer / BioNTech vaccine for 12-15 years, which will be the first vaccine to be authorized for adolescents in their 27 countries. European.

The vaccine is “well tolerated” by the young people and we have a “pass of major inquiries” concerning secondary effects, declared by a conference of Marco Cavaleri, responsible for the vaccination strategy of EMA.

This authorization marks a new advance in the European vaccination strategy. L’Allemagne announced the intention to open the 7 June vaccination against Covid-19 with miners of more than 12 years.

The vaccine has been used for this year in the United States and Canada.

“As a first, the committee of medicines for human use of EMA to approve the use of Pfizer / BioNTech vaccine for adolescents from 12 to 15 years”, according to M. Cavaleri.

The European Commissioner for Health Stella Kyriakides is on Twitter for the authorization of Pfizer’s EMA for young people, all of whom know that vaccination is a choke that should be “by parents for children”.

Accelerated evaluation

L’EMA, bassee a Amsterdam, avait début mai lancé une évaluation accelelerée des données transmises par les developpeurs de vaccins pour son authorisation aux 12-15 ans Allemand BioNTech for this tranche of training in the EU.

The study of Pfizer / BioNTech is based on 2,260 adolescents, and a review of the 1,005 youngsters who administered the vaccine did not develop the Covid-19, but 16 children of the 978 who had a placebo injection ont attrapa le virus, a précisé l’EMA.

The American Modern Biotechnology Society is annually announcing this vaccine, using the ARN technology that Pfizer / BioNTec, this “high efficiency” for adolescents aged 12 to 17 years, completing the results.

The patron saint of Moderna, Stéphane Bancel, announced the French herald The journal of the society that had to take care of the “debut one” of a demand for authorization of the market in the European Union with its anti-vaccination vaccine les 12-17 ans.

The three most common cases of cardiac problems in adolescents and young adults are vaccinated on this day by the American sanitary authorities, without the fact that vaccination is not established for the moment.

Myocardial signals, a inflammation of the cardiac muscle, this is relevant for people with ARC messaging, not the Prevention Centers and the disease against young people (CDC), the principle of the Federal Agency for Public Health. .

Interrogé, the European regulator has declared that it has “examined” the problem that is most important, “there is no indication” that the problem lies in the vaccine.



Source link

Leave a Comment